A fire continues to burn unchallenged as various stakeholders take sides over the anticipated depth and timing of mobile app regulation. It appears this most recent iteration flamed up after the Food and Drug Administration issued an “it has come to our attention” letter to Biosense for its UChek urine analyzer.
Source: Sparks fly over mHealth regs
Leave a Reply
You must be logged in to post a comment.